Healthcare, technology, energy, consumer goods, and more. Every day, Motley Fool analysts break down a specific industry and the stocks making headlines. Questions? Comments? Email us at [email protected].
On this week’s episode, we’ve got another deal to break down, with Brookfield Infrastructure Partners announcing a plan to take Genesee and Wyoming Railroad private. Motley Fool Contributor Matt Dila…
After building Canopy Growth into the world’s biggest pot stock, CEO Bruce Linton has been terminated by the company’s board of directors. Here’s what you need to know about his exit, the company’s f…
Endeavor, the world’s largest and longest running talent agency and owner of the UFC, recently filed its S-1 to go public. At the same time, an ongoing feud between the Writers Guild of America and m…
The June jobs report shows that our economy is creating far more jobs than expected, and this could make the Federal Reserve hesitant to cut rates as expected. In this episode of Industry Focus: Fina…
Description: With the 4th of July holiday this week, we’re bringing all the Industry Focus Hosts together to break down the biggest stories of the year so far. In Part 3, we share our wish lists of c…
With the 4th of July holiday this week, we’re bringing all the Industry Focus Hosts together to break down the biggest stories of the year so far. In Part 2, we break down some of the biggest trends …
With the 4th of July holiday this week, we’re bringing all the Industry Focus Hosts together to break down the biggest stories of the year so far. In Part 1, we discuss the state of the stock market …
It's been a big news week for Apple -- the company scooped up a self-driving start up, released new figures on Apple Music, and its design head is heading out. We break it all down on today's show.
S…
Earlier this month, Raytheon and United Technologies announced a “merger of equals,” promising to create the world’s second largest aerospace company by total revenues. At the same time, United Techn…
Shannon Jones and Jason Moser breakdown the proposed megamerger between AbbVie and Allergan. Also, Jason Moser shares his thinking and the stocks behind his “Healthcare and Wealthcare” basket.
Check …
On this week’s episode of Industry Focus: Consumer Goods host Jason Moser and Fool.com contributor Dan Kline dig into the burgeoning world of augmented reality and talk about the many different ways …
In this week's episode of Industry Focus: Financials, host Dylan Lewis and Fool.com contributor Matt Frankel, CFP discuss two recent news stories. As expected, the Federal Reserve held interest rates…
A proposed law could be big trouble for the business models of tech giants like Facebook, Google, and Twitter. We explain the laws that currently allow these companies to host user content without be…
Earlier this month, FedEx announced that it would no longer provide domestic express service to Amazon. What does this breakup mean for Amazon, e-commerce, and the future of logistics? Motley Fool Co…
Most investors will never come in contact with the products that are made by medical device companies. That fact can make it hard for them to research these types of businesses. However, when a medic…
America’s malls are changing. Some well-known retail brands have gone away replaced by digital retailers. That has forced mall operators to be creative in finding alternative ways to fill space. That…
On this week’s episode of Industry Focus: Financials host Jason Moser sits down with Brendan Mathews, VP of Motley Fool Ventures to talk about working in venture capital, the types of companies they'…
Another tech unicorn is going public -- Slack! We break down how the SaaS communication company works, its financials and its $17B valuation. We also explain the company's curious name, and why it ha…
It’s been a wild couple weeks for Fiat Chrysler and Renault. After Fiat made a merger offer in late May, Renault shareholders Nissan and the French government balked at the deal, leading Fiat to with…
Earlier this month, industry watchers gathered at the annual American Society of Clinical Oncology (ASCO) conference to discuss the latest research in the battle against cancer. In today's show, biot…